Atcef T 250mg/31.25mg Injection
Marketer
Atishya Biotech
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Atcef T 250mg/31.25mg Injection
Ceftazidime/Sulbactam 250mg/31.25mg injection is a dual-action antibiotic. This medication combats various bacterial infections by inhibiting microbial growth and propagation. Administration must be under a doctor's direct guidance; adhere strictly to the prescribed dosage schedule. Complete the entire course of treatment, even with symptom improvement, as premature cessation can compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Report worsening side effects or allergic reactions (such as rash, pruritus, edema, or dyspnea) immediately to your physician. Inform your doctor of all current medications, especially if you're pregnant or breastfeeding. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing, driving should be avoided if drowsiness or dizziness occurs. Adequate rest, nutrition, and hydration are essential for optimal recovery. Your healthcare provider may order blood tests to monitor treatment response.
Primary Ingredients of Atcef T 250mg/31.25mg Injection
No text provided to rephrase.
Uses of Atcef T 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Atcef T 250mg/31.25mg Injection:
The medication will be administered by your physician or their qualified staff. Self-medication is strongly discouraged.
Common Side effects of Atcef T 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Atcef T 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Atcef T 250mg/31.25mg Injection works:
Ceftriaxone/Tazobactam (Atcef T 250mg/31.25mg Injection) unites two active agents to combat bacterial infections. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering bacterial survival. Tazobactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thereby augmenting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
No adverse reactions are associated with the concurrent ingestion of alcohol and Atcef T 250mg/31.25mg Injection.
PregnancySAFE IF PRESCRIBED
Ceftazidime/Sulbactam 250mg/31.25mg injection is typically deemed safe for use in pregnancy. Preclinical trials in animals have revealed minimal or no harmful effects on fetal development; nevertheless, data from human studies are scarce.
Breast feedingCAUTION
Cefazolin/Sulbactam 250mg/31.25mg injection requires careful consideration during lactation. Mothers should temporarily discontinue breastfeeding throughout treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
Ceftazidime/Sulbactam 250mg/31.25mg injection can cause drowsiness, blurred vision, and dizziness. Refrain from driving if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Data regarding Atcef T 250mg/31.25mg Injection use in individuals with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
The 250mg/31.25mg Atcef T injection requires careful administration in individuals with significant hepatic impairment; dosage modification may be necessary. Medical advice is recommended. Dosage changes for this injection are not advised for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Atcef T 250mg/31.25mg Injection :
Omit doses of Atcef T 250mg/31.25mg Injection only after contacting your physician.
Facts to Know About Atcef T 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently